Need Help?
Contact Us

BE THE CEO OF CTO


While others are waiting, you’re innovating. And that can make all the difference in your CTO program. Now you can leverage the hybrid approach to treat chronic total occlusions safely — with maximum efficiency and success. And we’ll be there alongside you, with specialized training, ongoing case support, and, of course, unique tools.

CTOs occur in as many as 30% of patients with significant coronary artery disease. (1,2) CTOs occur in as many as 30% of patients with significant coronary artery disease. (1,2)
Patients with CTOs are most often treated with medical therapy or coronary artery bypass graft (CABG) rather than PCI. (3) Patients with CTOs are most often treated with medical therapy or coronary artery bypass graft (CABG) rather than PCI. (3)
Recent meta-analyses and large registries have shown that successful CTO PCI is associated with symptom relief, a reduction in long-term mortality, and a lower need for coronary artery bypass graft (CABG) surgery. (4,5) Recent meta-analyses and large registries have shown that successful CTO PCI is associated with symptom relief, a reduction in long-term mortality, and a lower need for coronary artery bypass graft (CABG) surgery. (4,5)

CROSSBOSS™ Coronary CTO Crossing Catheter

Designed to quickly and safely deliver a guidewire via the true lumen or subintimal pathways, CROSSBOSS Catheter gives you total access to coronary chronic total occlusions.

STINGRAY™ LP Coronary CTO Re-Entry System

Designed for reliability, safety, and predictability, the STINGRAY LP System allows the operator to accurately target and re-enter the true lumen from a subintimal position.

TRAPPER™ Exchange Device

Engineered with a tip-to-hub core wire for durability, TRAPPER Exchange Device facilitates device exchanges without losing wire position—while maximizing the efficiency of your complex cases.

STAY UP TO DATE ON COMPLEX PCI

Receive emails on the latest advances in Complex PCI.

Top